BoeingvsStrata Critical Medical

BA and SRTA stock compared: price, dividend, valuation and results, from SEC filings.

SRTA

Strata Critical Medical, Inc.

$5.51

Value $479M

-4.51%
SRTA's page

Boeing (BA) has a market value of $135B and Strata Critical Medical (SRTA) $479M. Over the last year, with dividends, BA moved -12.3% and SRTA +8.0%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BA$135B

    SRTA$479M

    BA is 281 times SRTA

  • Revenue, 12 months

    BA$94.9B

    SRTA$281M

    BA is 338 times SRTA

  • Net income, 12 months

    BA$7.7B

    SRTA-$25M

  • Operating margin

    BA10.3%

    SRTA-6.6%

    16.9 points apart

  • ROIC

    BA14.7%

    SRTA-5.2%

    19.9 points apart

  • P/E

    BA18.4

    SRTA–

  • Dividend yield

    BA0.0%

    SRTA0.0%

    About the same

  • 5-year return

    BA-22.4%

    SRTA-45.1%

    22.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BA-22.4%

SRTA-45.1%

5010020222023202420252026
Returns by period
PeriodBAWith dividendsSRTAWith dividends
1 year since November 12, 2025-12.3%Price -12.3%+8.0%Price +8.0%
3 years since November 13, 2023-16.2%-5.7% a yearPrice -16.2%+68.0%+18.9% a yearPrice +68.0%
5 years since November 12, 2021-22.4%-4.9% a yearPrice -22.4%-45.1%-11.3% a yearPrice -45.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BABoeingSRTAStrata Critical Medical

Valuation

BASRTA
Valuation
Price$171.50$5.51
Market value$135B$479M
Enterprise value (EV)$160B$438M
P/E18.4–
P/E, 5-year median––
P/B20.61.7
EV/EBIT16.4–
Free cash flow yield0.0%0.2%

Results and growth

BASRTA
Results and growth
Revenue, 12 months$94.9B$281M
Net income, 12 months$7.7B-$25M
Free cash flow, 12 months$16M$806.0K
Earnings per share, 12 months$9.69-$0.30
Revenue growth, year on year34.5%34.3%
Revenue growth a year, past+9.0%over 5 years+53.1%over 5 years
EPS growth a year, past––

Margins and returns on capital

BASRTA
Margins and returns on capital
Gross margin9.4%21.6%
Operating margin10.3%-6.6%
Net margin8.1%-8.8%
ROIC14.7%-5.2%
ROE241.7%-8.8%

Balance sheet

BASRTA
Balance sheet
Cash$20.7B$42M
Total debt$45.9B$3.6M
Net debt / EBITDA2.2–
Interest cover4.0×–

Dividends and buybacks

BASRTA
Dividends and buybacks
Dividend yield––
Dividend per share, 12 months––
Dividend growth a year, past––
Buyback yield––
Shareholder yield––

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BA or SRTA

Didn't find what you were looking for?

Ask us
Which is bigger, Boeing or Strata Critical Medical?

By market value, Boeing ($135B) is about 281.0 times Strata Critical Medical ($479M), at today's prices.

How did BA and SRTA stock do over the last 5 years?

Since November 12, 2021, BA's price moved -22.4% and SRTA's -45.1%. With dividends: BA -22.4% (-4.9% a year), SRTA -45.1% (-11.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, BA or SRTA?

Neither paid a dividend over the last twelve months: Boeing and Strata Critical Medical return money to shareholders, if they do, in other ways, such as buybacks.

Which has the higher profit margins, Boeing or Strata Critical Medical?

Over the last twelve months, the net margin was 8.1% for Boeing and -8.8% for Strata Critical Medical, and the operating margin 10.3% and -6.6%. Revenue was $94.9B and $281M.

Which is the better investment, Boeing or Strata Critical Medical?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.